Cobra polypeptide cytotoxin I and marine worm polypeptide cytotoxin A-IV are potent and selective inhibitors of phospholipid-sensitive Ca2+-dependent protein kinase  by Kuo, J.F. et al.
Volume 153, number 1 FEBS LETTERS March 1983 
Cobra polypeptide cytotoxin I and marine worm polypeptide 
cytotoxin A-IV are potent and selective inhibitors of 
phospholipid-sensitive Ca2+-dependent protein kinase 
J.F. Kuo, Robert L. Raynor, Gonzalo J. Mazzei, Randall C. Schatzman, R. Scott Turner and 
William R. Kern 
Department of Pharmacology, Emory University SchooI of Medicine, Atlanta, GA 30322 and Department of 
Pharmacology and Therapeutics, University of Florida CoHege of Medicine, Gaine~ille, FL 32610, USA 
Received 12 January 1983 
The effects of a number of pofypeptide cytotoxins and neurotoxins on various protein kinases were 
examined. It was found that cobra cytotoxin I and marine worm cytotoxin A-IV effectively and specifically 
inhibited phospholipid-sensitive Ca’” -dependent protein kinase (PL-Ca-PK) relative to myosin light chain 
kinase and cyclic nucleotide-dependent protein kinases. Inhibition of PL-Ca-PK by these cytotoxins could 
be overcome by phosphatidylserine. Neurotoxins, in comparison, were much less effective inhibitors. The 
present findings indicated that these polypeptide cytotoxins, unlike other agents reported to date, were 
selective inhibitors of PL-Ca-PK and could be used to differentiate Ca 2+-dependent events regulated by 
phospholipid or calmodulin. 
Cl.?’ Phospholipid Protein phosphoryfation Neurotoxin 
1. INTRODUCTION 
Diverse groups of animals are known to produce 
poiypeptide toxins. The neurotoxins act by binding 
to specific receptors which regulate ion channels 
[il. Cytotoxins, on the other hand, are surface- 
active amphipathic agents which usually interact 
with membrane lipid biiayer components (such as 
phospholipids), producing a generalized toxic 
response in cardiovascular and other tissues [2-41. 
The ubiquitous occurrence of PL-Ca-PK has been 
established [5,6]. This enzyme is distinct from 
other species of Ca’+-dependent protein kinases re- 
quiring calmoduiin as a cofactor, as exemplified by 
MLCK [7]. PL-Ca-PK, present in ceils as soluble 
and membrane-bound forms [S], has been purified 
and characterized [g-12]. In a continuing effort to 
elucidate the regulatory mechanism and functional 
roles of PL-Ca-PK, we examined the effects of cer- 
tain purified poiypeptide cytotoxins and neurotox- 
ins on PL-Ca-PK relative to MLCK. We found 
that certain cytotoxins were potent and, unlike 
other agents reported to date, were relatively seiec- 
tive inhibitors of PL-Ca-PK. 
2. EXPERIMENTAL 
2.1. Toxins and other reagents 
Abbreviations: PL-Ca-PK, phospholipid-sensitive 
Ca2+-dependent protein kinase; MLCK, myosin light 
chain kinase; A-PK and G-PK, cyclic AMP- and cyclic 
GMP-dependent protein kinases, respectively 
Pure cytotoxin I and neurotoxin I (both from 
cobra Naja naju oxiana) were purchased from 
Calbiochem-Behring (San Diego CA). Meiittin and 
apamin (both from bee venom) and 
phosphatidyiserine (from bovine brain) were from 
Sigma (St Louis MO); poiymyxin B sulfate was 
from Pfizer (New York NY); calmoduiin was from 
Sciogen (Detroit MI). Cytotoxin A-IV [4] and 
neurotoxin B-IV [13], both from marine worm 
Cere~rff~~/~s lactaeus, were purified as described. 
Phosphatidylserine was microdispersed to clarity 
by sonication. 
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2.2. Enzymes 3. RESULTS AND DISCUSSION 
PL-Ca-PK was purified to 80-95% 
homogeneous from bovine heart [9], to 
homogeneous from pig spleen [ 1 I], and to about 
80% homogeneous from pig brain as in [9] (un- 
published). Homogeneous cardiac MLCK [7] and 
partially purified cardiac A-PK [ 141 and G-PK [ 151 
were prepared as reported. 
PL-Ca-PK was incubated in 0.2 ml 50 mM 
Pipes (pH 6.5) and activated by 2 fig 
phosphatidylserine and 0.5 mM CaClz [9-111. 
MLCK was incubated in 0.2 ml 25 mM Tris-HCl 
(pH 7.5) and activated by 0.5 pg calmodulin and 
0.1 mM CaC12 [16]. The amounts of 
phosphatidylserine and calmodulin chosen were 
such that they supported the Ca’+-stimulated ac- 
tivities of the enzyme 50-60% of that maximally 
stimulated (12-35-fold) by Ca2+. A-PK and G-PK 
were incubated in 0.2 ml 25 mM potassium 
phosphate (pH 7.5) and activated lo-15-fold by 
0.5 FM cyclic AMP and cyclic GMP, respectively 
[14,15]. The activities of the enzymes were linear 
with respect o the amount of enzyme and the time 
of incubation. All experiments were performed 2 
or 3 times and the average activity values 
stimulated by Ca2+, cyclic AMP or cyclic GMP 
Marine worm cytotoxin A-IV and cobra 
cytotoxin I (cardiotoxin I) were more effective 
than cobra neurotoxin I in inhibiting various pro- 
tein kinases purified from bovine hearts (fig.1). 
The inhibition by toxins, in a decreasing order, was 
PL-Ca-PK > MLCK 2> A-PK and G-PK. Cytotox- 
in A-IV also more specifically inhibited PL-Ca-PK 
compared to a cardiac phosphodiesterase 
stimulated by calmodulin/Ca2+ (not shown). 
Inhibition of PL-Ca-PK by cytotoxin A-IV and 
cytotoxin I was progressively overcome by increas- 
ing concentrations of phosphatidylserine (fig.2). 
Detailed kinetic analysis indicated that both 
cytotoxins A-IV and I inhibited the enzyme com- 
petitively with respect to phosphatidylserine, with 
Ki-values of 0.3 and 0.8 PM, respectively. The 
results suggested that these cytotoxins may interact 
with the phosphatidylserine, or with a 
hydrophobic region on the enzyme to which the 
phospholipid cofactor binds. We reported [15] that 
melittin, a polypeptide cytotoxin from bee venom, 
inhibited PL-Ca-PK and MLCK competitively 
with respect o their respective cofactor. 
The relative activity of various toxins on cardiac 
PL-Ca-PK MLCK were compared (table 1). It ap- were reported or used for calculation. 
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Fig. 1. Comparative inhibition of various protein kinases by polypeptide toxins. The enzymes used were purified from 
bovine heart. Results similar to those shown above for the cardiac PL-Ca-PK were also obtained for the enzyme from 
pig spleen and brain. 
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PHOSPHATlOYLSERlNE ( pg ) 
Fig.2. Reversal by phosphatidylserine of cytotoxin 
inhibition of cardiac PL-Ca-PK. Results similar to those 
shown above for the cardiac enzyme were also noted for 
the spleen enzyme. 
peared that cytotoxins (cytotoxin A-IV, cytotoxin 
I, and melittin) were generally more effective in- 
hibitors than neurotoxins (neurotoxin B-IV, 
neurotoxin I, and apamin) for PL-Ca-PK. It was 
also noted that cytotoxins A-IV and I as well as 
neurotoxin I were generally more specific in- 
hibitors for PL-Ca-PK than for MLCK, as in- 
dicated by their ratios of ZCsc-values (concentra- 
tions causing a 50% inhibition) for the two en- 
zymes of about 0.03-0.05. In contrast, neurotoxin 
B-IV was a more specific inhibitor for MLCK, as 
indicated by an ZCse ratio of 10. Little specificity, 
however, was noted for the two bee venom toxins 
(melittin and apamin), with ZCSO ratios of 0.58 and 
0.46, respectively. Interestingly, polymyxin B (a 
membrane-active polypeptide antibiotic) was as ef- 
fective as all cytotoxins tested in inhibiting PL-Ca- 
PK; furthermore, like cytotoxins A-IV and I but 
unlike melittin, it exhibited a specificity for PL- 
Ca-PK inhibition as indicated by an ZCSO ratio of 
0.02. It is worth noting that, of the 3 neurotoxins 
studied, apamin was more effective than neurotox- 
ins B-IV and I in inhibiting PL-Ca-PK. Apamin is 
one of the smallest neurotoxin polypeptides known 
[3]. The ability of apamin, but not other larger 
neurotoxins, to inhibit PL-Ca-PK may be related 
to its smaller size. 
Since we found that cytotoxin I was more active 
than neurotoxin I in inhibiting PL-Ca-PK 
(presumably in part via interaction between the 
cytotoxin and phosphatidylserine), we suspected 
Table 1 
Comparative potency of polypeptide toxins to inhibit cardiac PL-Ca-PK and MLCK 
Source and toxin KSO @g/ml) ZCso ratio of 
PL-Ca-PK : MLCK 
PL-Ca-PK MLCK 
Marine worm 
Cytotoxin A-IV 13 ( 1.3)a 360 ( 34.6) 0.04 
Neurotoxin B-IV 750 (125 ) 75 ( 12.5) 10.0 
Cobra 
Cytotoxin I (cardiotoxin I) 26 ( 3.7) 750 ( 107.1) 0.03 
Neurotoxin I 475 ( 67.9) > 10000 (1428.5) < 0.05 
Honey bee 
Melittin (cytotoxin)b 7 ( 2.5) 12 ( 4.3) 0.58 
Apamin (neurotoxin) 60 ( 30.0) 130 ( 65.0) 0.46 
Bacterium 
Polymyxin B (antibiotic) 2 ( 2.0) 105 ( 105.0) 0.02 
a The values in parentheses are in FM, using the following M,-values: cytotoxin A-IV, 10400; neurotoxin B-IV, 6000; 
cytotoxin I and neurotoxin I, both 7000; melittin, 2800; apamin, 2000; polymyxin B, 1000 
b The same results were obtained using either a commercial (Sigma) preparation or a pure preparation of melittin, an 
original gift of Dr G. Kreil (Institute of Molecular Biology, Austrian Academy of Science) [16] 
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that the phospholipid could more effectively pro- 
tect mice from a lethal dose of cytotoxin I than 
that of neurotoxin I. We found that this was in- 
deed the case. The time required to kill male mice 
(25 g body wt, CF-1 strain, Charles River Breeding 
Labs, Wilmington MA) by a subcutaneous injec- 
tion (in 0.26 ml saline) of cytotoxin I (1500 pg) was 
15.8 + 3.3 min (mean f standard error, n = 6). If 
phosphatidylserine (400 pug) was mixed with 
cytotoxin I before injection, the killing time was 
significantly increased to 32.5 + 8.2 min (n = 8, p 
< 0.01). The killing time seen for neurotoxin I 
(1OOrg) was 20.2 + 4.0 min (n = 6); mixing of 
phosphatidylserine (400 pg) with neurotoxin I, 
however, did not increase the killing time (24.4 + 
4.9 min, n = 6). The lethal doses of toxins used 
have been predetermined to be the minimum 
amounts that kill mice in 15-20 min after the in- 
jection. There was no noticeable effect when the 
phospholipid was injected alone. 
The present studies indicated that cytotoxin A- 
IV, cytotoxin I as well as polymyxin B were effec- 
tive and relatively selective inhibitors for PL-Ca- 
PK compared to MLCK. These findings are of 
some potential importance, because we noted 
previously that many inhibitors studied, such as 
phenothiazine antipsychotic drugs [ 171, palmi- 
toylcarnitine (181, and melittin [16] are nearly 
equipotent in inhibiting the phospholipid/Ca’+- 
and calmodulin/Ca2+-stimulated protein phospho- 
rylation systems or, in some cases, inhibit the latter 
system even slightly more effectively. It appears 
that cytotoxins A-IV and I and polymyxin B could 
be used as agents to differentiate Ca2+-dependent 
reactions or processes regulated by either phos- 
pholipid or calmodulin. It remains unclear whether 
an inhibition by these cytotoxins of protein 
phosphorylation is directly or indirectly related to 
their well-recognized toxic effects on cells. 
ACKNOWLEDGEMENTS 
This work was supported by USPHS grants 
HL-15696, NS-17608, GM-25849 and 
T32-GM-07594, and by NSF grant BNS-76-06266. 
REFERENCES 
111 
PI 
[31 
141 
PI 
[61 
171 
Bl 
[91 
1101 
t111 
WI 
1131 
1141 
1151 
1161 
1171 
1181 
Albuquerque, E.X., Eldefrawi, A.T. and 
Eldefrawi, M.E. (1981) in: Handbook of 
Experimental Pharmacology, Snake Venoms (Lee, 
C.Y. ed) ~01.52, pp.377-402, Springer Verlag, 
Berlin, New York. 
Lee, C.Y. (1979) in: Advances in 
Cytopharmacology (Ceccarelli, B. and Clement, F. 
eds) ~01.3, pp.l-16, Raven, New York. 
Habermann, E. (1972) Science 177, 314-322. 
Kern, W.R. and Blementhal, K.M. (1978) J. Biol. 
Chem. 253, 5752-5757. 
Takai, Y., Kishimot, A., Iwasa, Y., Kawahara, Y., 
Mori, T. and Nishizuka, Y. (1979) J. Biol. Chem. 
254, 3692-3695. 
Kuo, J.F., Andersson, R.G.G., Wise, B.C., 
Mackerlova, L., Salomonsson, I., Katoh, N., 
Shoji, M. and Wrenn, R.W. (1980) Proc. Natl. 
Acad. Sci. USA 77, 7039-7043. 
Walsh, M.P., Vallet, B., Autric, F. and Demaille, 
J.G. (1979) J. Biol. Chem. 254, 12136-12144. 
Katoh, N. and Kuo, J.F. (1982) Biochem. Biophys. 
Res. Commun. 106, 590-595. 
Wise, B.C., Raynor, R.L. and Kuo, J.F. (1982) J. 
Biol. Chem. 257, 8481-8488. 
Wise, B.C., Glass, D.B., Chou, C.-H.J., Raynor, 
R.L., Katoh, N., Schatzman, R.C., Turner, R.S., 
Kibler, R.F. and Kuo, J.F. (1982) J. Biol. Chem. 
257, 8489-8495. 
Schatzman, R.C., Raynor, R.L., Fritz, R.B. and 
Kuo, J.F. (1983) Biochem. J., in press. 
Kikkawa, U., Takai, Y., Minakuchi, R., Inohara, 
S. and Nishizuka, Y. (1982) J. Biol. Chem. 257, 
13341-13348. 
Kern, W.R. (1976) J. Biol. Chem. 251, 4184-4192. 
Kuo, J.F., Krueger, B.K., Sanes, J.R. and 
Greengard, P. (1970) Biochim. Biophys. Acta 212, 
79-91. 
Shoji, M., Patrick, J.G., Davis, C.W. and Kuo, 
J.F. (1977) Biochem. J. 161, 213-221. 
Katoh, N., Raynor, R.L., Wise, B.C., Schatzman, 
R.C., Turner, R.S., Helfman, D.M., Fain, J.N. 
and Kuo, J.F. (1982) Biochem. J. 202, 217-224. 
Wrenn, R.W., Katoh, N., Schatzman, R.C. and 
Kuo, J.F. (1981) Life Sci. 29, 725-733. 
Katoh, N., Wrenn, R.W., Wise, B.C., Shoji, M. 
and Kuo, J.F. (1981) Proc. Natl. Acad. Sci. USA 
78, 4813-4817. 
186 
